Literature DB >> 9445134

Stringent criteria for histological diagnosis of koilocytosis fail to eliminate overdiagnosis of human papillomavirus infection and cervical intraepithelial neoplasia grade 1.

M A Abadi1, G Y Ho, R D Burk, S L Romney, A S Kadish.   

Abstract

Overdiagnosis of HPV infection in cervical biopsies results in increased health care costs and unnecessary surgical procedures. Stringent criteria for histological diagnosis of koilocytosis were evaluated, using molecular detection of HPV DNA (polymerase chain reaction and Southern blot hybridization) as gold standard. Colposcopic biopsy specimens from 511 patients were studied, including 76 with referral diagnoses of negative cervix and 241 with CIN 1 or koilocytosis. Referral diagnoses for low-grade lesions failed to distinguish between HPV-infected and uninfected patients. False-positive rate for prediction of HPV infection was 74.8%. Biopsy specimens reevaluated using stringent diagnostic criteria showed increasing prevalence of HPV infection among patients whose biopsy specimens showed negative (43.7%), minimal (52.4%), or definite (69.5%) features of koilocytosis (P = .001). Similarly, subjects infected with high viral load or oncogenic HPV infection were more likely to be identified (P = .004 and .04, respectively). Despite increased predictive value of stringent diagnostic criteria, significant number of patients diagnosed as having CIN 1/koilocytosis (34.0%) did not in fact have HPV infection. Because most low-grade lesions spontaneously regress, patients with histological diagnosis of CIN 1 or HPV infection should be observed for a period of several months before definitive ablative treatment is undertaken.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445134     DOI: 10.1016/s0046-8177(98)90390-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes.

Authors:  L Rozendaal; J Westerga; J C van der Linden; J M Walboomers; F J Voorhorst; E K Risse; M E Boon; C J Meijer
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

Review 2.  Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

Authors:  J P A Baak; A-J Kruse; S J Robboy; E A M Janssen; B van Diermen; I Skaland
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

3.  Genetic variants in TAP are associated with high-grade cervical neoplasia.

Authors:  Mark H Einstein; Suzanne Leanza; Lydia G Chiu; Nicolas F Schlecht; Gary L Goldberg; Bettie M Steinberg; Robert D Burk
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

4.  Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III.

Authors:  Mark H Einstein; Anna S Kadish; Robert D Burk; Mimi Y Kim; Scott Wadler; Howard Streicher; Gary L Goldberg; Carolyn D Runowicz
Journal:  Gynecol Oncol       Date:  2007-06-22       Impact factor: 5.482

Review 5.  Cervical Pre-cancers: Biopsy and Immunohistochemistry.

Authors:  Meherbano Kamal
Journal:  Cytojournal       Date:  2022-06-14       Impact factor: 2.345

6.  A comprehensive analysis of penile cancer in the region with the highest worldwide incidence reveals new insights into the disease.

Authors:  Antonio Augusto Lima Teixeira Júnior; Syomara Pereira da Costa Melo; Jaqueline Diniz Pinho; Thaís Bastos Moraes Sobrinho; Thalita Moura Silva Rocha; Denner Rodrigo Diniz Duarte; Liseana de Oliveira Barbosa; Wesliany Everton Duarte; Marta Regina de Castro Belfort; Kelly Gomes Duarte; Antonio Lima da Silva Neto; José de Ribamar Rodrigues Calixto; Lúcio Cristiano Paiva Paiva; Francisco Sérgio Moura Silva do Nascimento; Antonio Machado Alencar Junior; André Salim Khayat; Rita da Graça Carvalhal Frazão Corrêa; Joyce Santos Lages; Rodolfo Borges Dos Reis; Wilson Silva Araújo; Gyl Eanes Barros Silva
Journal:  BMC Cancer       Date:  2022-10-15       Impact factor: 4.638

7.  Koilocytes indicate a role for human papilloma virus in breast cancer.

Authors:  J S Lawson; W K Glenn; B Heng; Y Ye; B Tran; L Lutze-Mann; N J Whitaker
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.